Cheng Yin, Tobiloba Adanma Adenekan, Chuanjie Deng, Johnni Hansen, Chisom N Iwundu, Julia E Heck
{"title":"Application of an obstetric comorbidity index to predict childhood cancer risk: a population based case-control study in Denmark.","authors":"Cheng Yin, Tobiloba Adanma Adenekan, Chuanjie Deng, Johnni Hansen, Chisom N Iwundu, Julia E Heck","doi":"10.1038/s41416-025-03120-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Maternal health during pregnancy appears to impact childhood cancer risk, yet comprehensive studies remain scarce. This study investigates associations between childhood cancer and multiple maternal comorbidities.</p><p><strong>Methods: </strong>A population-based case-control study was conducted using Danish national registers, with maternal health conditions identified from the National Patient Register and Medical Births Registry. We employed the Obstetric Comorbidity Index using ICD-8 and ICD-10 codes. The study population (1977-2013) included 6419 cases and 160484 matched controls. Conditional logistic regression estimated pediatric cancer risk.</p><p><strong>Results: </strong>A maternal comorbidity score of one or more was linked to acute lymphocytic leukemia (ALL; OR = 1.07, 95%CI: 1.03-1.12), retinoblastoma (OR = 1.08, 95%CI: 0.94-1.23), and rhabdomyosarcoma (OR = 1.11, 95%CI: 0.98-1.26). Pre-existing diabetes (OR = 1.82, 95%CI: 1.28-2.59), previous cesarean delivery (OR = 1.20, 95%CI: 1.02-1.41), and gestational hypertension (OR = 1.27, 95%CI: 1.01-1.59) were associated with increased cancer risks in offspring. Slightly higher risks were noted for non-Hodgkin lymphoma (OR = 1.05, 95%CI: 0.96-1.16) and Burkitt lymphoma (OR = 1.08, 95%CI: 0.92-1.27) among children whose mothers had one or more comorbidities.</p><p><strong>Conclusion: </strong>An obstetric comorbidity index can predict childhood cancer risk. This highlights the need for targeted interventions to reduce adverse health consequences for offspring.</p>","PeriodicalId":9243,"journal":{"name":"British Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41416-025-03120-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Maternal health during pregnancy appears to impact childhood cancer risk, yet comprehensive studies remain scarce. This study investigates associations between childhood cancer and multiple maternal comorbidities.
Methods: A population-based case-control study was conducted using Danish national registers, with maternal health conditions identified from the National Patient Register and Medical Births Registry. We employed the Obstetric Comorbidity Index using ICD-8 and ICD-10 codes. The study population (1977-2013) included 6419 cases and 160484 matched controls. Conditional logistic regression estimated pediatric cancer risk.
Results: A maternal comorbidity score of one or more was linked to acute lymphocytic leukemia (ALL; OR = 1.07, 95%CI: 1.03-1.12), retinoblastoma (OR = 1.08, 95%CI: 0.94-1.23), and rhabdomyosarcoma (OR = 1.11, 95%CI: 0.98-1.26). Pre-existing diabetes (OR = 1.82, 95%CI: 1.28-2.59), previous cesarean delivery (OR = 1.20, 95%CI: 1.02-1.41), and gestational hypertension (OR = 1.27, 95%CI: 1.01-1.59) were associated with increased cancer risks in offspring. Slightly higher risks were noted for non-Hodgkin lymphoma (OR = 1.05, 95%CI: 0.96-1.16) and Burkitt lymphoma (OR = 1.08, 95%CI: 0.92-1.27) among children whose mothers had one or more comorbidities.
Conclusion: An obstetric comorbidity index can predict childhood cancer risk. This highlights the need for targeted interventions to reduce adverse health consequences for offspring.
期刊介绍:
The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research.It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.